MO · Consumer

ALTRIA GROUP, INC.

Ranked earnings events from SEC filings, earnings calls, press releases and news. Full Picture: everything published this earnings window

News · 2026-11-07

• Quarterly Dividend IncreaseImportance 40 · Surprise 42
  Altria raised its quarterly dividend to $1.11 per share, according to the third-quarter earnings coverage. A separate report described the dividend as carrying a 5.8% yield. The digest did not state the prior quarterly…
• Quarterly Earnings PerformanceImportance 13 · Surprise 6
  Altria reported third-quarter 2026 revenue of $5.44 billion and EPS of $1.52. Both revenue and EPS exceeded analyst expectations, although the reports did not provide the size of the beats. The digest did not report…

News · 2026-11-06

• Quarterly Earnings PerformanceImportance 27 · Surprise 6
  Altria reported third-quarter 2026 sales of US$5,441 million and net income of US$2,518 million. Earnings per share from continuing operations were US$1.51 for the quarter. The report also noted growth in the on!…
• Oral Nicotine Pouch GrowthImportance 17 · Surprise 24
  A third-party investment article identifies growth in Altria’s on! nicotine pouch brand as part of the company’s smoke-free product mix. It provides no sales, volume, market-share, or growth-rate figures for on!. The…
• Capital Markets ActivityImportance 17 · Surprise 24
  Altria filed an effective automatic shelf registration statement (Form S-3ASR) with the U.S. Securities and Exchange Commission on October 29, 2026. The registration gives the company flexibility to raise capital in…

News · 2026-11-05

• Quarterly Dividend IncreaseImportance 32 · Surprise 24
  Altria increased its quarterly dividend to $1.11 per share. The reported dividend implies an annualized yield of 5.7%. The report also said Altria’s quarterly earnings beat analyst estimates, but provided no earnings…

News · 2026-11-04

• Quarterly Dividend IncreaseImportance 26 · Surprise 24
  Altria increased its quarterly dividend to $1.11 per share. The report did not state the previous dividend rate or the size or percentage of the increase. The dividend increase was reported alongside quarterly EPS of…
• Quarterly Earnings PerformanceImportance 22 · Surprise 24
  Altria reported quarterly revenue of $5.44 billion. Quarterly EPS was $1.52. The report said both quarterly earnings and revenue topped estimates, but gave no year-over-year or sequential comparisons.

News · 2026-11-02

• Oral Nicotine Pouch GrowthImportance 44 · Surprise 58
  Altria expanded its on! PLUS 12-milligram nicotine pouches nationwide in the third quarter of 2026, with mint, wintergreen and tobacco varieties. The rollout targets growing demand among adult consumers for higher…
• Guidance / OutlookImportance 40 · Surprise 42
  Third-party reporting says Altria slightly raised its full-year 2026 adjusted EPS guidance. The revised guidance is $5.70 per share at the midpoint. The report does not provide the prior midpoint or identify a change…
• Revenue Performance and MixImportance 18 · Surprise 14
  Altria reported third-quarter 2026 revenue of $5.44 billion, up 3.6% year over year. Revenue exceeded analysts’ $5.31 billion estimate by 2.4%. The reported figures indicate quarterly revenue growth, but the digest…
• Net Income and EPS PerformanceImportance 14 · Surprise 14
  Altria reported third-quarter 2026 adjusted EPS of $1.52 per share. Adjusted EPS was 0.9% above analysts’ consensus estimate of $1.51. The digest reports adjusted EPS but does not provide net income or an adjusted EPS…
• Operating Margin DriversImportance 13 · Surprise 6
  Altria’s third-quarter 2026 operating margin was 60.9%. The margin was in line with the same quarter a year earlier. The digest attributes the broader quarterly results to smoke-free momentum and price discipline, but…

News · 2026-11-01

• Guidance / OutlookImportance 47 · Surprise 60
  Altria raised its full-year 2026 outlook following its third-quarter results. Analysts maintained their revenue and EPS forecasts for 2027, indicating no significant change to their forecasts for that year.
• Smoke-Free Product GrowthImportance 20 · Surprise 24
  Third-party reporting said Altria’s smoke-free portfolio showed significant growth and strategic momentum in the third quarter of 2026. The on! nicotine pouch brand was highlighted as a key contributor to that…
• Quarterly Earnings PerformanceImportance 19 · Surprise 6
  Altria reported third-quarter 2026 revenue of $5.4 billion, 2.5% above analyst predictions. Statutory earnings per share were $1.51, in line with analyst forecasts. The company also reported that third-quarter results…

News · 2026-10-30

• Guidance / OutlookImportance 47 · Surprise 60
  On its third-quarter 2026 earnings call, Altria raised its full-year earnings outlook. The report did not provide the revised earnings range or quantify the change. Management cited resilient profitability in the core…
• Revenue Performance and MixImportance 37 · Surprise 32
  Altria’s third-quarter 2026 revenue net of excise taxes increased 3.6% year over year to $5.44 billion, an increase of approximately $189 million and above the $5.3 billion consensus estimate. Total net revenue rose 1%…
• Quarterly Dividend IncreaseImportance 32 · Surprise 24
  Altria increased its quarterly dividend to $1.11 per share. The reported dividend yield was 5.8%. The digest did not specify the prior quarterly dividend or the percentage increase.
• Smoke-Free Product GrowthImportance 23 · Surprise 24
  Third-party reporting says Altria’s on! nicotine pouch portfolio is growing. A separate earnings-call summary described nicotine-pouch investments, particularly on!, as driving growth in the oral tobacco category. The…

10-Q · 2026-10-29

• Oral Tobacco Revenue and MarginsImportance 72 · Surprise 58
  For the nine months ended September 30, 2026, oral tobacco net revenues fell 1.2% to $2.070 billion, as a $140 million decline from shipment volume was partly offset by $121 million from higher pricing, including…
• Dividends and Capital ReturnsImportance 69 · Surprise 50
  Altria paid $5.330 billion in dividends during the first nine months of 2026, up 3.0% from $5.175 billion in the prior-year period. In August 2026, the Board increased the quarterly dividend 4.7%, from $1.06 to $1.11…
• Settlement and FDA PaymentsImportance 66 · Surprise 40
  Altria estimated average charges to cost of sales of $3.0 billion annually for the next three years for State Settlement Agreement payments and FDA user fees, based on current agreements and estimates. Payments for…
• State Tobacco RestrictionsImportance 59 · Surprise 42
  As of October 26, 2026, California, Massachusetts, New Jersey, New York, Rhode Island, Utah and the District of Columbia had enacted flavor restrictions affecting tobacco products; California’s law covers most flavored…
• Operating Income and MarginsImportance 54 · Surprise 40
  For the nine months ended September 30, 2026, operating income increased 14.0% to $9,405 million from $8,248 million, primarily because OCI was higher and the prior-year comparison included an $873 million non-cash…
• Excise Tax TrendsImportance 54 · Surprise 40
  Excise taxes on products declined 10.8% to $2,116 million for the nine months ended September 30, 2026, from $2,373 million in the prior-year period. For the third quarter, excise taxes declined 15.8%, a $130 million…
• Net Income and EPS PerformanceImportance 52 · Surprise 30
  For the nine months ended September 30, 2026, reported net earnings attributable to Altria rose 20.1% to $6,999 million from $5,830 million, and diluted EPS increased 21.2% to $4.18 from $3.45. Adjusted net earnings…
• E-Vapor Goodwill ImpairmentImportance 52 · Surprise 42
  Altria recorded a non-cash, pre-tax impairment charge of $873 million for the nine months ended September 30, 2025 to reduce the e-vapor reporting unit’s goodwill to estimated fair value. The impairment followed the…
• Liquidity and Debt PositionImportance 49 · Surprise 32
  At September 30, 2026, Altria held $2.7 billion in cash and cash equivalents and had up to $3.0 billion available under its senior unsecured revolving credit agreement; the company reported compliance with the…
• Oral Tobacco Demand WeaknessImportance 49 · Surprise 32
  Altria’s oral tobacco products segment domestic shipment volume fell 5.4% in the first nine months of 2026, or an estimated 5% after adjusting for trade inventory movements, as retail share losses and inventory…
• Revenue Performance and MixImportance 42 · Surprise 14
  For the nine months ended September 30, 2026, Smokeable Products net revenues were $13.532 billion, up $465 million (3.6%), while reported OCI increased $327 million (3.9%) to $8.668 billion and adjusted OCI rose $345…
• Operating Cash Flow TrendsImportance 42 · Surprise 14
  Net cash provided by operating activities increased to $6.151 billion in the first nine months of 2026 from $6.019 billion in the comparable 2025 period. The increase primarily reflected lower State Settlement…
• Equity Investment IncomeImportance 41 · Surprise 48
  For the nine months ended September 30, 2026, income or losses from investments in equity securities improved by $89 million, or 22.4%, primarily because of higher income from Altria’s ABI investment. In the third…
• FDA PMTA Review LitigationImportance 34 · Surprise 42
  In September 2026, Helix, NJOY and certain trade partners sued the FDA in the U.S. District Court for the Northern District of Texas, alleging that the agency routinely fails to issue marketing orders within the…
• FDA Tobacco Product RegulationImportance 34 · Surprise 42
  In May 2026, the FDA issued guidance on enforcement for certain e-vapor and oral nicotine pouch products with pending PMTAs, generally deprioritizing enforcement for specified products undergoing scientific review or…
• Graphic Warning Label LitigationImportance 34 · Surprise 42
  The FDA’s March 2020 rule requires 11 graphic cigarette warnings, but its enforcement has been blocked or delayed through litigation. In August 2026, the U.S. Court of Appeals for the Fifth Circuit affirmed a…
• Cigarette Pricing ActionsImportance 32 · Surprise 24
  PM USA implemented multiple cigarette list-price increases in 2026, including increases effective January 18, April 12 and July 19, generally raising Marlboro (excluding Mainline Menthol and 72s Menthol) and L&M by…
• Oral Nicotine Pouch GrowthImportance 31 · Surprise 32
  The U.S. nicotine pouch category expanded to 59.8% of the U.S. oral tobacco category in the first nine months of 2026, up 7.6 share points, while total oral tobacco category industry volume grew an estimated 5.5% over…
• FDA Tobacco Product StandardsImportance 31 · Surprise 24
  In January 2025, the FDA proposed a nicotine cap for cigarettes and certain combustible tobacco products, including little cigars, cigarillos and most large cigars; the comment period closed in September 2025, and the…
• Illicit E-Vapor EnforcementImportance 26 · Surprise 24
  The FDA and U.S. Customs and Border Protection have taken steps to impede imports of illicit flavored disposable e-vapor products, including seizing unauthorized products and issuing warning letters to importers.…
• Tobacco Excise Tax PressureImportance 26 · Surprise 24
  U.S. tobacco products face substantial excise taxes, and the weighted-average state cigarette tax rose from $0.36 per pack at the end of 1998 to $2.02 as of October 26, 2026; Utah enacted a cigarette tax increase in…
• Income Tax Rate ChangesImportance 25 · Surprise 22
  For the three months ended September 30, 2026, the provision for income taxes increased $76 million, or 10.9%, compared with the prior-year quarter. The increase primarily reflected a prior-year net income tax benefit…
• Cigarette Shipment and Share TrendsImportance 25 · Surprise 32
  For the nine months ended September 30, 2026, Altria’s domestic cigarette shipment volume declined 2.8%, while volume adjusted for trade inventory movements fell an estimated 4%, compared with an estimated 5% decline…
• Macroeconomic Consumer PressureImportance 10 · Surprise 6
  Through the third quarter of 2026, U.S. adult nicotine consumers faced inflationary pressure on discretionary income, particularly price-sensitive consumers. Geopolitical uncertainty and Middle East developments…

Earnings call · 2026-10-29

• Guidance / OutlookImportance 74 · Surprise 68
  Altria raised its 2026 adjusted diluted EPS guidance to $5.66–$5.74, representing growth of 4.5%–6% from the 2025 base of $5.42. Earlier in the year, the company had guided to growth of 2.5%–5%. CFO Heather Newman said…
• Capital Return ProgramImportance 69 · Surprise 50
  Altria returned more than $6 billion to shareholders in the first nine months of 2026, including $5.3 billion in dividends and $735 million in share repurchases. In August, the Board increased the quarterly dividend…
• Regulatory RiskImportance 52 · Surprise 42
  Altria said FDA enforcement guidance had allowed Helix to move through the regulatory process more efficiently, but warned that guidance can change. Helix and NJOY filed a complaint against the FDA during the quarter,…
• Litigation and Legal RiskImportance 52 · Surprise 42
  Helix and NJOY brought legal action against the FDA during the third quarter. Their complaint asks the court to require the agency to establish a product-review process that meets the 180-day timeframe set by Congress.…
• Smokeable Products PerformanceImportance 49 · Surprise 32
  PM USA adjusted operating companies income increased 3.9% to $3.1 billion in the third quarter and 4.1% to $8.8 billion for the first nine months of 2026. Adjusted OCI margin was 64.5% for the quarter, up 0.1…
• Illicit E-Vapor Market DynamicsImportance 49 · Surprise 32
  Management said the e-vapor market remains predominantly driven by illicit products, which it views as a threat to the long-term harm-reduction opportunity. It estimated approximately 20 million adult vapers at the end…
• Oral Tobacco Revenue PerformanceImportance 43 · Surprise 32
  Oral tobacco products adjusted OCI decreased 3.7% to $443 million in the third quarter and 4% to $1.3 billion for the first nine months of 2026. Adjusted OCI margins were 66.4% for the quarter and 66.8% for the first…
• Oral Nicotine Pouch GrowthImportance 42 · Surprise 40
  Management estimated that the oral tobacco category grew 5.5% over the past six months, with nicotine pouches increasing 5.8 share points in the third quarter to more than 60% of the category. On! shipment volume rose…
• Equity Investment IncomeImportance 34 · Surprise 30
  Altria recorded $191 million of adjusted equity earnings from ABI in the third quarter of 2026, an increase of 21.7% year over year. Management described its ABI stake as a financial investment and said its goal is to…
• Product Launch and TransitionImportance 34 · Surprise 42
  Helix expanded on! PLUS 12-milligram products nationally across mint, wintergreen, and tobacco, responding to demand for higher nicotine strengths. Blueberry Mint and Mango Pineapple flavor extensions reached retail in…
• Strategic InitiativesImportance 34 · Surprise 42
  Altria said it plans to return to the e-vapor market with NJOY ACE, but did not announce a timing for relaunch. Management characterized its approach as disciplined and focused on competing profitably over time, given…
• Competition and Market ShareImportance 31 · Surprise 32
  Management described the nicotine pouch category as increasingly competitive, with elevated competitive investment during the quarter and new products contributing to market activity. On! retail share was up 0.1 point…
• Macroeconomic Consumer PressureImportance 25 · Surprise 6
  Management said the overall cost of goods and services had risen roughly 30% since 2021, sustaining pressure on adult smokers’ household budgets. More recent increases in gas prices further constrained discretionary…
• Balance Sheet and LiquidityImportance 13 · Surprise 6
  Altria reported a debt-to-EBITDA ratio of 1.9x as of September 30, 2026. Management said this was in line with the company's target of approximately 2x. The call disclosed this leverage measure but did not provide a…
• Premium Cigarette Demand PressureImportance 13 · Surprise 6
  Management said continuing consumer economic pressure and inflation are weighing on smokers, while nicotine has historically been more resilient than other consumer packaged goods categories. The company attributed…
• Cigarette Shipment and Share TrendsImportance null · Surprise 32
  Domestic cigarette volumes declined 2.9% in the third quarter and 2.8% for the first nine months; after adjustment for trade inventory movements, management estimated declines of 4%, slightly below the industry's…